OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...
AJMC ®: Demodex blepharitis has a high estimated prevalence in the United States. However, few US studies of this disease exist. Why is this disease so understudied here? JACKSON: The main reason ...
Tarsus to Host Eye Care Leaders Webcast on Unmet Needs in Demodex Blepharitis and Potential of TP-03
Interested parties may access the webcast here or at the events section of the Tarsus website. A replay will be available for a limited time at the same address. About TP-03TP-03 (lotilaner ophthalmic ...
Neda Shamie, MD, summarizes the prevalence and clinical manifestations of Demodex Blepharitis. This is a video synopsis/summary of an Insights involving Neda Shamie, MD. Until recently, there were no ...
Demodex blepharitis is a highly prevalent, yet often undiagnosed eyelid disease that impacts approximately 25 million eye care patients in the U.S. “We know that many patients struggle with eyelid ...
XDEMVY is the first and only approved therapeutic for Demodex blepharitis, a highly prevalent eyelid disease that impacts approximately 25 million eye care patients in the U.S. XDEMVY targets the root ...
Welcome to the Mite Party. In its latest effort to raise awareness about demodex blepharitis, an eye condition that affects 25 million Americans, Tarsus Pharmaceuticals is throwing a party — a Mite ...
Waking up with itchy eyelids might seem like a typical allergy symptom, but it could also be a sign of eye mites. Eye mites, or Demodex, are microscopic organisms that live at the base of your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback